Lake Fish Company Inc
Letter data
- Company
- Lake Fish Company Inc
- Recipient
- Mr. Dale D. Trent | President | Lake Fish Company Inc | 1014 W Water Street | Sandusky | , | OH | 44870 | United States
- Issue date
- 2020-04-01
- Posted date
- Not available
- FDA office
- HAF East Division V
- Subject
- Not available
- Product
- Not available
- CMS ID
- 489196
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Lake Fish Company Inc
MARCS-CMS 489196 —
April 01, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Recipient Name
Mr. Dale D. Trent
Recipient Title
President
Lake Fish Company Inc
1014 W Water Street
Sandusky
,
OH
44870
United States
Issuing Office:
HAF East Division V
United States
(513) 679-2700
Dear Mr. Trent:
The Food and Drug Administration has completed an evaluation of your firms’ corrective actions in response to our Warning Letter (CIN-16-489196-09) issued on February 17, 2016. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Allison C. Hunter
Compliance Officer
HAF East Division V
Content current as of:
04/10/2020